My understanding is that another phase 3 trial is required before it will go up for FDA Approval.
Same goes with the CLBP trial... that is why they partnered up for a European trial.
If the current phase 3 CHF trial is successful, next step should be a US partner to fund and run the pivotal phase 3 trial.
Unless the goal posts have changed?
REVASCOR - CHF Insurance Coverage, page-11
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |